FGFR3 and urothelial carcinoma: To illustrate our results in relation to published reports using genomic sequencing data, we added a review table for FGFR-3 analysis and comparison table analysis of two studies, including a study by Pietzak et al. [25] and the TCGA data, to compare the rate of specific mutations across urothelial carcinomas.